Abiopharma

NIQ lance sa solution Product Intelligence pour dynamiser le commerce basé sur l’IA

NIQ führt „Product Intelligence“ ein, um den KI-gesteuerten Handel voranzutreiben

NIQ推出產品智慧解決方案，賦能AI驅動的商務發展

Johnson Controls Announces Quarterly Dividend

Dormant shares – change in the number of shares

Ceased to be an interested party - Harel Insurance Investments and Financial Services Ltd.

Clinical trial NCT07076121: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT05506878 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-09-30 → 2026-04-13 3. primary completion date: 2026-06-30 → 2026-01-13 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06952504: start date: 2025-05-22 → 2025-05-21.

Clinical trial NCT05006716: enrollment: 614 → 645 participants.